EssilorLuxottica/€EL

05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX

About EssilorLuxottica

EssilorLuxottica is a French-Italian multinational corporation operating in the eyewear and eye care industry. It was formed through the merger of the French ophthalmic optics company Essilor and the Italian eyewear company Luxottica in 2018. The company designs, manufactures, and distributes ophthalmic lenses, optical equipment, and eyewear, including well-known brands such as Ray-Ban, Oakley, and Persol, as well as licensed brands like Chanel and Prada. Headquartered in Charenton-le-Pont, France, and Milan, Italy, EssilorLuxottica has a global presence with operations in over 150 countries. Its strategic positioning is underscored by its integrated business model that encompasses both retail and wholesale distribution, leveraging its extensive portfolio of proprietary and licensed brands.

Ticker

€EL
Sector

Primary listing

PAR

Employees

200,076

EssilorLuxottica Metrics

BasicAdvanced
€122B
51.52
€5.15
0.75
€3.95
1.49%

What the Analysts think about EssilorLuxottica

Analyst ratings (Buy, Hold, Sell) for EssilorLuxottica stock.

Bulls say / Bears say

Excluding foreign-exchange impacts, Q2 revenue grew by 7.3% year-on-year at constant exchange rates, reflecting underlying demand strength across Professional Solutions and Direct-to-Consumer channels. (Reuters)
Sales of Ray-Ban Meta smart glasses more than tripled in the first half of 2025, positioning EssilorLuxottica as a leader in the emerging AI-enabled wearable computing market and opening significant new revenue streams. (Bloomberg)
The agreement to acquire Optegra’s network of over 70 ophthalmic clinics expands EssilorLuxottica’s footprint into high-margin medical technology services, diversifying its business beyond eyewear and strengthening long-term growth prospects. (Reuters)
Adjusted operating profit for the first half of 2025 rose 4.1% to €2.53 billion, falling just short of the €2.55 billion Visible Alpha consensus and highlighting margin pressures from U.S. tariffs and cost inflation. (Reuters)
Currency headwinds from a weaker U.S. dollar capped Q2 revenue growth at 3.2% on a reported basis, underscoring FX volatility risks given EssilorLuxottica’s significant North American exposure. (Reuters)
Management is exploring shifting part of its production to the U.S. in response to American tariffs, a move that could increase capital expenditures and operational complexity if implemented. (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 7 Sept 2025.

EssilorLuxottica Financial Performance

Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%

EssilorLuxottica Earnings Performance

Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.

Buy €EL

Sign up or log in to buy
Capital at risk
Market closed

Upcoming events

No upcoming events
FAQs